Published in J Neurosci on April 01, 2002
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron (2012) 1.83
Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry (2008) 1.48
Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res (2008) 1.46
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci (2010) 1.44
Activity-dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination. Proc Natl Acad Sci U S A (2005) 1.42
Metabolic changes in schizophrenia and human brain evolution. Genome Biol (2008) 1.39
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Mitochondrial involvement in psychiatric disorders. Ann Med (2008) 1.38
Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32
Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med Genomics (2009) 1.31
Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry (2010) 1.30
The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS One (2008) 1.29
Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet (2010) 1.26
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 1.23
Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics (2008) 1.17
Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One (2008) 1.17
Analyzing schizophrenia by DNA microarrays. Biol Psychiatry (2011) 1.16
Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci (2011) 1.11
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm (Vienna) (2008) 1.10
Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J (2003) 1.09
Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia. Neuropsychopharmacology (2013) 1.09
Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS One (2012) 1.07
Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry (2013) 1.07
Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry (2012) 1.06
Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl Psychiatry (2012) 1.05
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry (2009) 1.04
Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS One (2008) 1.02
Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. Biochim Biophys Acta (2010) 1.01
Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. Mol Psychiatry (2015) 0.99
Immune system disturbances in schizophrenia. Biol Psychiatry (2013) 0.99
Implication of the polyamine system in mental disorders. J Psychiatry Neurosci (2008) 0.97
Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS One (2007) 0.97
Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. Neuroimage (2009) 0.96
Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology (2014) 0.96
A cross-laboratory comparison of expression profiling data from normal human postmortem brain. Neuroscience (2010) 0.95
The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis (2011) 0.95
Gene expression in the etiology of schizophrenia. Schizophr Bull (2008) 0.93
Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. BMC Med Genomics (2009) 0.93
Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood. Am J Med Genet B Neuropsychiatr Genet (2010) 0.93
Dynamics of subcellular proteomes during brain development. J Proteome Res (2012) 0.91
Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology (2013) 0.91
Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry (2012) 0.91
Infragranular gene expression disturbances in the prefrontal cortex in schizophrenia: signature of altered neural development? Neurobiol Dis (2009) 0.90
Lysine metabolism in mammalian brain: an update on the importance of recent discoveries. Amino Acids (2013) 0.90
Schizophrenia: an integrative approach to modelling a complex disorder. J Psychiatry Neurosci (2006) 0.89
Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes. Eur Arch Psychiatry Clin Neurosci (2011) 0.88
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci (2013) 0.87
BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. Adolesc Psychiatry (2005) 0.86
Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia. Eur Child Adolesc Psychiatry (2009) 0.86
Relayed (13)C magnetization transfer: detection of malate dehydrogenase reaction in vivo. J Magn Reson (2006) 0.86
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC Psychiatry (2009) 0.85
Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. J Neurochem (2003) 0.85
Schizophrenia as a disorder of molecular pathways. Biol Psychiatry (2014) 0.85
Epigenetic mechanisms in schizophrenia. Dialogues Clin Neurosci (2014) 0.85
The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia. J Neural Transm (Vienna) (2009) 0.85
Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected]. PLoS One (2013) 0.85
Gene expression profiling of the brain: pondering facts and fiction. Neurobiol Dis (2011) 0.84
Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia. Biol Psychiatry (2016) 0.83
Molecular links between mitochondrial dysfunctions and schizophrenia. Mol Cells (2012) 0.82
Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. Neuroscience (2010) 0.82
Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia. Mol Neuropsychiatry (2015) 0.81
Is brain banking of psychiatric cases valuable for neurobiological research? Clinics (Sao Paulo) (2008) 0.81
Retracted Identification of gene ontologies linked to prefrontal-hippocampal functional coupling in the human brain. Proc Natl Acad Sci U S A (2014) 0.80
A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology. Neuropsychopharmacology (2013) 0.79
Method designed to respect molecular heterogeneity can profoundly correct present data interpretations for genome-wide expression analysis. PLoS One (2015) 0.79
Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiency. PLoS One (2008) 0.79
Metabolomic analysis reveals metabolic disturbance in the cortex and hippocampus of subchronic MK-801 treated rats. PLoS One (2013) 0.79
The proteome of schizophrenia. NPJ Schizophr (2015) 0.79
FBXL21 association with schizophrenia in Irish family and case-control samples. Am J Med Genet B Neuropsychiatr Genet (2008) 0.79
Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report. Transl Psychiatry (2016) 0.78
GABBR1 has a HERV-W LTR in its regulatory region--a possible implication for schizophrenia. Biol Direct (2013) 0.78
A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia. Ment Illn (2010) 0.78
The epigenomics of schizophrenia, in the mouse. Am J Med Genet B Neuropsychiatr Genet (2017) 0.77
Expression profiling of drug response--from genes to pathways. Dialogues Clin Neurosci (2006) 0.77
Glutathione Deficit Affects the Integrity and Function of the Fimbria/Fornix and Anterior Commissure in Mice: Relevance for Schizophrenia. Int J Neuropsychopharmacol (2015) 0.76
A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study. Clin Psychopharmacol Neurosci (2014) 0.76
Transcriptome sequencing of the choroid plexus in schizophrenia. Transl Psychiatry (2016) 0.75
Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations. Transl Psychiatry (2017) 0.75
Non-synonymous variants in the AMACR gene are associated with schizophrenia. Schizophr Res (2010) 0.75
Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia. Transl Psychiatry (2016) 0.75
Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia. Neuropsychopharmacology (2015) 0.75
Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia. Schizophr Res (2016) 0.75
NeuN(+) neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure. Schizophr Res (2016) 0.75
Visualizing K48 Ubiquitination during Presynaptic Formation By Ubiquitination-Induced Fluorescence Complementation (UiFC). Front Mol Neurosci (2016) 0.75
Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder. Transl Psychiatry (2015) 0.75
Imine reductases: a comparison of glutamate dehydrogenase to ketimine reductases in the brain. Neurochem Res (2013) 0.75
Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia. Transl Neurosci (2016) 0.75
DNA Damage in Major Psychiatric Diseases. Neurotox Res (2016) 0.75
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder. Transl Psychiatry (2015) 0.75
Altered brain arginine metabolism in schizophrenia. Transl Psychiatry (2016) 0.75
Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study. Psychiatry Investig (2017) 0.75
Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci (2008) 8.14
Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci (2003) 4.86
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell (2005) 4.25
Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci (2007) 4.06
A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A (2006) 3.55
The future of psychiatry as clinical neuroscience. Acad Med (2009) 3.31
Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa. J Low Genit Tract Dis (2015) 3.30
Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry (2008) 3.16
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol (2006) 2.93
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull (2008) 2.81
The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis (2008) 2.76
A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71
Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci (2007) 2.70
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther (2009) 2.53
Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry (2014) 2.46
Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet (2012) 2.44
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37
Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci (2009) 2.33
Conflict of interest. Am J Psychiatry (2006) 2.30
Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci (2003) 2.18
A molecular signature of depression in the amygdala. Am J Psychiatry (2009) 2.18
Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci (2005) 2.18
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (2007) 2.02
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96
Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology (2008) 1.93
Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry (2011) 1.91
How the timing and quality of early experiences influence the development of brain architecture. Child Dev (2010) 1.87
Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep (2010) 1.87
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One (2013) 1.83
Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex (2002) 1.77
Early experience modifies the postnatal assembly of autonomic emotional motor circuits in rats. J Neurosci (2005) 1.76
The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol (2009) 1.74
Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet (2002) 1.68
Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry (2006) 1.66
Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry (2002) 1.65
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry (2008) 1.64
Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex (2008) 1.61
Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry (2005) 1.61
Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61
Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling. Nature (2009) 1.59
Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex. Biol Psychiatry (2009) 1.58
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci (2006) 1.58
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull (2012) 1.57
Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry (2007) 1.57
Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res (2012) 1.55
Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology (2002) 1.55
Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control (2009) 1.52
The generic enhancement of photochromic dye switching speeds in a rigid polymer matrix. Nat Mater (2005) 1.52
A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci (2008) 1.51
GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast (2011) 1.51
Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother (2010) 1.48
Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biol Psychiatry (2006) 1.47
Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry (2014) 1.44
Conflict of interest, round 2. Am J Psychiatry (2006) 1.44
Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism. Neuron (2005) 1.44
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits. Biol Psychiatry (2004) 1.43
Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. Biol Psychiatry (2012) 1.43
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav (2002) 1.40
Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry (2012) 1.40
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol (2011) 1.38
Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics (2009) 1.37
Amygdala gene expression correlates of social behavior in monkeys experiencing maternal separation. J Neurosci (2007) 1.35
Functional properties of fast spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. J Neurophysiol (2004) 1.35
Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry (2006) 1.34
Mapping auditory core, lateral belt, and parabelt cortices in the human superior temporal gyrus. J Comp Neurol (2005) 1.34
Interneuron diversity in layers 2-3 of monkey prefrontal cortex. Cereb Cortex (2008) 1.33
Single-neuron RNA-Seq: technical feasibility and reproducibility. Front Genet (2012) 1.32
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol (2011) 1.32
Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J Neurosci (2011) 1.30
Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry (2010) 1.30
Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb Cortex (2010) 1.30
Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron (2012) 1.29
Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol (2003) 1.29
Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.28